{"created":"2023-05-15T16:36:46.337047+00:00","id":9927,"links":{},"metadata":{"_buckets":{"deposit":"30af053c-8142-4c3a-b168-c8d37b1b9e2b"},"_deposit":{"created_by":2,"id":"9927","owners":[2],"pid":{"revision_id":0,"type":"depid","value":"9927"},"status":"published"},"_oai":{"id":"oai:nagasaki-u.repo.nii.ac.jp:00009927","sets":["8:9"]},"author_link":["40044","40049","40051","40053","40054","40048","40047","40055","40043","40050","40056","40058","40046","40045","40057","40052"],"item_2_alternative_title_19":{"attribute_name":"その他のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"A Clinical Study of 34 Malignant Pleural Mesothelioma Patients Treated with Pemetrexed from Nagasaki Thoracic Oncology Group"}]},"item_2_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2012-09-21","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"4","bibliographicPageEnd":"374","bibliographicPageStart":"371","bibliographicVolumeNumber":"52","bibliographic_titles":[{"bibliographic_title":"肺癌"},{"bibliographic_title":"Haigan@@@Japanese Journal of Lung Cancer","bibliographic_titleLang":"en"}]}]},"item_2_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"目的．悪性胸膜中皮腫に対するペメトレキセドを含む化学療法の効果と有害事象についてレトロスペクティブな検討を行った．方法．2007年2月～2009年12月に長崎胸部腫瘍研究グループ関連施設においてペメトレキセドを含む化学療法を行った悪性胸膜中皮腫34例を検討．結果．男性28例，女性6例，年齢中央値68歳（53～81歳）でアスベスト曝露があった症例は26例．病理組織型は上皮型16例，肉腫型10例，二相型5例，不明3例であった．初回化学療法25例，既治療8例，30例がペメトレキセド・シスプラチン併用療法，3例がペメトレキセド・カルボプラチン併用療法，1例がペメトレキセド単剤療法を受けていた．ペメトレキセド（500 mg/m2）・シスプラチン（75 mg/m2）併用療法を受けた24例のGrade 3以上の毒性は白血球減少2例（8.3％），好中球減少5例（20.8％），消化器毒性2例（8.3％）で，奏効率12.5％，生存期間中央値14.4ヶ月であった．結論．実臨床でのペメトレキセド・シスプラチン併用療法の効果と有害事象は，過去の前向き試験の結果とほぼ同程度であった．","subitem_description_type":"Abstract"},{"subitem_description":"Objective. We analyzed the clinical features and outcomes of malignant pleural mesothelioma patients treated with pemetrexed. Method. From February 2007 to December 2009, 34 patients enrolled with the Nagasaki Thoracic Oncology Group were treated with pemetrexed. Results. Of the 34 patients, 28 were men and 6 were women with a median age of 68 years old (range 53 to 81). Twenty-six patients (76.5%) had exposed to asbestos. The histological subtype was epithelioid in 16 patients, sarcomatoid in 10 patients, biphasic in 5 patients, unknown in 3 patients. Twenty-five patients were chemotherapy-naive patients and 8 patients had received prior chemotherapy. Thirty patients had received pemetrexed and cisplatin chemotherapy. Three patients had received pemetrexed and carboplatin chemotherapy. One patient had received pemetrexed monotherapy. In pemetrexed (500 mg/m 2) and cisplatin (75 mg/m 2) group, grade 3 or 4 leukocytopenia was recorded in 2 patients (8.3%), grade 3 or 4 neutropenia was recorded in 5 patients (20.8%), grade 3 or 4 gastrointestinal toxicities were recorded in 2 patients (8.3%). The response rate was 12.5%, the median survival was 14.4 months. Conclusion. In this study clinical efficacy and toxicities of malignant pleural mesothelioma patients treated with pemetrexed and cisplatin chemotherapy are comparable to previous prospective studies.","subitem_description_type":"Abstract"}]},"item_2_description_63":{"attribute_name":"引用","attribute_value_mlt":[{"subitem_description":"肺癌, 52(4), pp.371-374; 2012","subitem_description_type":"Other"}]},"item_2_full_name_3":{"attribute_name":"著者別名","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"40051","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Ikeda, Takaya"}]},{"nameIdentifiers":[{"nameIdentifier":"40052","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Nakamura, Yoichi"}]},{"nameIdentifiers":[{"nameIdentifier":"40053","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Fukuda, Minoru"}]},{"nameIdentifiers":[{"nameIdentifier":"40054","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Fukuda, Masaaki"}]},{"nameIdentifiers":[{"nameIdentifier":"40055","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Soda, Hiroshi"}]},{"nameIdentifiers":[{"nameIdentifier":"40056","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Kinoshita, Akitoshi"}]},{"nameIdentifiers":[{"nameIdentifier":"40057","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Soejima, Yoshifumi"}]},{"nameIdentifiers":[{"nameIdentifier":"40058","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Kohno, Shigeru"}]}]},"item_2_publisher_33":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"日本肺癌学会"}]},"item_2_relation_12":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"10.2482/haigan.52.371","subitem_relation_type_select":"DOI"}}]},"item_2_rights_13":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"© 2012 日本肺癌学会"}]},"item_2_source_id_7":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"03869628","subitem_source_identifier_type":"ISSN"}]},"item_2_source_id_8":{"attribute_name":"EISSN","attribute_value_mlt":[{"subitem_source_identifier":"13489992","subitem_source_identifier_type":"ISSN"}]},"item_2_text_62":{"attribute_name":"出版者別言語","attribute_value_mlt":[{"subitem_text_value":"Japan Lung Cancer Society"}]},"item_2_version_type_16":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"池田, 喬哉"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"中村, 洋一"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"福田, 実"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"福田, 正明"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"早田, 宏"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"木下, 明敏"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"副島, 佳文"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"河野, 茂"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2020-12-22"}],"displaytype":"detail","filename":"haigan52_4_371.pdf","filesize":[{"value":"240.6 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"haigan52_4_371.pdf","url":"https://nagasaki-u.repo.nii.ac.jp/record/9927/files/haigan52_4_371.pdf"},"version_id":"14ab5658-fe67-4fb0-896e-ad8408f419d6"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Chemotherapy","subitem_subject_scheme":"Other"},{"subitem_subject":"Cisplatin","subitem_subject_scheme":"Other"},{"subitem_subject":"Malignant pleural mesothelioma","subitem_subject_scheme":"Other"},{"subitem_subject":"Pemetrexed","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"悪性胸膜中皮腫に対するペメトレキセドの実臨床における有用性の検討","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"悪性胸膜中皮腫に対するペメトレキセドの実臨床における有用性の検討"}]},"item_type_id":"2","owner":"2","path":["9"],"pubdate":{"attribute_name":"公開日","attribute_value":"2014-09-22"},"publish_date":"2014-09-22","publish_status":"0","recid":"9927","relation_version_is_last":true,"title":["悪性胸膜中皮腫に対するペメトレキセドの実臨床における有用性の検討"],"weko_creator_id":"2","weko_shared_id":-1},"updated":"2023-05-16T01:34:41.782788+00:00"}